BR9713582A - Vacinação in ovo contra doença de newcastle - Google Patents

Vacinação in ovo contra doença de newcastle

Info

Publication number
BR9713582A
BR9713582A BR9713582-8A BR9713582A BR9713582A BR 9713582 A BR9713582 A BR 9713582A BR 9713582 A BR9713582 A BR 9713582A BR 9713582 A BR9713582 A BR 9713582A
Authority
BR
Brazil
Prior art keywords
newcastle disease
ovo vaccination
against newcastle
vaccination against
ovo
Prior art date
Application number
BR9713582-8A
Other languages
English (en)
Inventor
Frans Gerrit Davelaar
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Publication of BR9713582A publication Critical patent/BR9713582A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Patente de Invenção: <B>"VACINAçãO IN OVO CONTRA DOENçA DE NEWCASTLE"<D>. A presente invenção refere-se a uma vacina para vacinação in ovo de aves domésticas contra infecção de Doenças de Newcastle. Esta vacina contém virus de Doenças de Newcastle da cepa com indicação interna de NDW, depositada em CNCM (Institut Pasteur) sob número I-781.
BR9713582-8A 1996-12-17 1997-12-16 Vacinação in ovo contra doença de newcastle BR9713582A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96203572A EP0848956A1 (en) 1996-12-17 1996-12-17 In ovo vaccination against Newcastle Disease
PCT/EP1997/007066 WO1998026800A1 (en) 1996-12-17 1997-12-16 In ovo vaccination against newcastle disease

Publications (1)

Publication Number Publication Date
BR9713582A true BR9713582A (pt) 2000-04-04

Family

ID=8224711

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713582-8A BR9713582A (pt) 1996-12-17 1997-12-16 Vacinação in ovo contra doença de newcastle

Country Status (18)

Country Link
US (1) US6348197B1 (pt)
EP (2) EP0848956A1 (pt)
JP (1) JP2001506253A (pt)
KR (1) KR100540856B1 (pt)
CN (1) CN1146443C (pt)
AR (1) AR010794A1 (pt)
AT (1) ATE271883T1 (pt)
AU (1) AU5758798A (pt)
BR (1) BR9713582A (pt)
CA (1) CA2273074C (pt)
DE (1) DE69730040T2 (pt)
DK (1) DK0938335T3 (pt)
ES (1) ES2224294T3 (pt)
HK (1) HK1022273A1 (pt)
PT (1) PT938335E (pt)
TW (1) TW537896B (pt)
WO (1) WO1998026800A1 (pt)
ZA (1) ZA9711333B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074614B1 (en) * 1999-07-27 2004-07-07 Akzo Nobel N.V. A recombinant Newcastle disease virus for in ovo vaccination
CA2312626A1 (en) 1999-07-27 2001-01-27 Akzo Nobel N.V. A recombinant newcastle disease virus as an embryo vaccine
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
EP1300157B1 (en) 2001-10-04 2005-10-26 Centrum voor Onderzoek in Diergeneeskunde en Agrochemie Attenuated mutant newcastle disease virus strains for in ovo vaccination and their use
MXPA04012881A (es) * 2002-06-21 2005-07-05 Wellstat Biologics Corp Administracion de virus terapeuticos.
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines
WO2004113518A1 (en) * 2003-06-20 2004-12-29 Microbix Biosystems Inc. Improvements in virus production
CN101460192A (zh) * 2006-03-30 2009-06-17 恩布里克斯公司 家禽疫苗接种的方法和组合物
FR2921387B1 (fr) * 2007-09-26 2012-04-20 Sanofi Pasteur Procede de production du virus de la grippe
CN102559607B (zh) * 2012-01-04 2013-03-27 扬州大学 新城疫病毒高粘膜免疫水平弱毒疫苗株ndv/lx及反向遗传构建系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
ATE112490T1 (de) * 1988-07-18 1994-10-15 Duphar Int Res Lebende newcastle-krankheit-virus-vakzine.
US5427791A (en) 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease

Also Published As

Publication number Publication date
AR010794A1 (es) 2000-07-12
DK0938335T3 (da) 2004-11-29
KR20000069501A (ko) 2000-11-25
ZA9711333B (en) 1999-06-17
EP0938335A1 (en) 1999-09-01
HK1022273A1 (en) 2000-08-04
DE69730040D1 (de) 2004-09-02
ES2224294T3 (es) 2005-03-01
KR100540856B1 (ko) 2006-01-12
CA2273074A1 (en) 1998-06-25
WO1998026800A1 (en) 1998-06-25
ATE271883T1 (de) 2004-08-15
DE69730040T2 (de) 2004-12-30
JP2001506253A (ja) 2001-05-15
TW537896B (en) 2003-06-21
US6348197B1 (en) 2002-02-19
PT938335E (pt) 2004-11-30
CA2273074C (en) 2008-04-29
CN1146443C (zh) 2004-04-21
CN1240360A (zh) 2000-01-05
AU5758798A (en) 1998-07-15
EP0938335B1 (en) 2004-07-28
EP0848956A1 (en) 1998-06-24

Similar Documents

Publication Publication Date Title
Irving et al. Histological changes in experimental periodontal disease in rats mono-infected with a gram-negative organism
BR9713582A (pt) Vacinação in ovo contra doença de newcastle
WO2003003941A3 (en) One dose vaccination with mycoplasma hyopneumoniae
ATE250937T1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
BR9608648A (pt) Vacinas de vírus vivos prrs de baixa patogenicidade processos para sua preparação
CA2215203A1 (en) Vaccines for plague
DE69534992D1 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
BR9713312B1 (pt) preparado de vacina para uso veterinário útil para produzir imunidade ativa contra uma doença bacteriana ou protozoária.
BR9407841A (pt) Processo para aperfeiçoar a ingestão de nutrientes de um animal semelhante a ruminante ou ruminante e preparação veterinária
DE69826019D1 (de) Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung
AU5628796A (en) Coccidiosis poultry vaccine
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
CA1339963C (en) Live combination vaccine containing infectious bronchitis virus
DE10399019I1 (de) Gefluegelkrankheit verursachende neue Bakterie unddaraus stammender Impfstoff
Shakir et al. Effect on experimental palatal candidosis in the Wistar rat of removal and re-insertion of acrylic appliances
CA2181862A1 (en) Mild newcastle disease virus vaccine
MXPA01005808A (es) Cepa de virus de enfermedad bursal infecciosa para administracion en huevo.
Raj et al. Cross‐reactive cellular immune responses in chickens vaccinated with live infectious bronchitis virus vaccine
AR003003A1 (es) Virus de la enfermedad de marek, una vacuna para la proteccion de aves de corral que contiene dicho virus y metodo para cultivarlo.
BR9706133A (pt) Mycoplasma synoviae atenuado vivo cultura microbiológica vacina para a proteção de aves domésticas processo para sua preparação e uso da cepa mycoplasma synoviae
ES2060740T3 (es) Vacunas de virus vivos para la enfermedad de newcastle.
Marschang et al. Virus isolation and vaccination of Mediterranean tortoises against a chelonid herpesvirus in a chronically infected population in Italy
WO1998039429A3 (en) Compositions for treatment of disorders involving programmed cell death
WO2004100640A3 (en) Marek’s disease virus vaccine

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/03/2008, OBSERVADAS AS CONDICOES LEGAIS.

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 13A, 14A E 15A ANUIDADE(S), CONFORME ART. 87 DA LPI 9.279.

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 13A, 14A E 15A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.